The Chemours Company (CC) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates declining sales and EBITDA across multiple segments, operational disruptions, and financial shortfalls. Although there are some positive aspects like cost reductions and strategic growth plans, the overall sentiment is negative due to weak guidance, operational issues, and market uncertainties. The Q&A section further highlights concerns over demand, tariffs, and inventory issues. Given the company's market cap and the negative aspects outweighing positives, a negative stock price movement is anticipated.
Key Financial Performance
Opteon sales growth Opteon sales maintained double-digit growth of 80% compared to the prior year quarter. This increase was primarily due to higher pricing and volume associated with sales into the stationary aftermarket in connection with the U.S. AIM Act's residential and commercial HVAC equipment transition this year.
Opteon Refrigerants share of total refrigerant sales Opteon Refrigerants now account for 80% of total refrigerant sales, an increase from 58% in the previous year. This growth was driven by the regulatory transition and effective commercial execution.
TSS adjusted EBITDA margin TSS achieved a 35% adjusted EBITDA margin, reflecting strong commercial discipline and profitable growth tied to the regulatory transition. However, this also included higher-than-anticipated onetime costs for liquid cooling product commercialization.
APM adjusted EBITDA APM's earnings performance was in line with expectations, supported by the return to normal operations at Washington Works after an external utility disruption and progress in portfolio management efforts, including the shutdown of the SPS Capstone product line.
TT adjusted EBITDA TT's adjusted EBITDA was below expectations due to sustained macro weakness in the global TiO2 market, seasonal trends, and near-term destocking. Sequential pricing strength in Western markets was offset by destocking, while non-Western markets saw sequential volume strength offset by pricing weakness.
Corporate cost structure The company made progress in reducing its underlying cost structure, with some favorable costs due to the timing of legal spending and continued cost reduction efforts.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Opteon Refrigerants: Achieved double-digit growth of 80% compared to the prior year quarter, driven by higher pricing and volume associated with sales into the stationary aftermarket. Opteon now accounts for 80% of total refrigerant sales, up from 58% last year.
Liquid cooling product: Continued investments to commercialize the product, with a recent successful technical qualification of two-phase immersion cooling fluid by Samsung Electronics.
Partnership with SRF Limited in India: Announced an agreement to support essential applications, positioning the company for a more flexible and robust operational footprint.
Global pricing increase for TT: Communicated a global pricing increase in the fourth quarter, reflecting the company's value in the market.
Manufacturing center of excellence: Resolved operational disruptions, enabling quicker response and enhanced issue mitigation.
Chemours Business System: Launched to apply lean principles for improvements in safety, quality, and efficiency across operations.
Shutdown of SPS Capstone product line: Completed as part of portfolio management efforts.
Critical minerals initiative: Focused on high-value minerals like monazite and zircon, with government funding of $10 million awarded for 2025 and 2026 to support innovative separation technology.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Macroeconomic Weakness: Persisting macroeconomic weakness affected economically sensitive sectors of the business, impacting overall performance.
Operational Disruptions: Anticipated operational disruptions were highlighted, though resolved, they posed risks to manufacturing and operational efficiency.
Higher Onetime Costs: Higher-than-anticipated onetime costs were incurred due to investments in commercializing liquid cooling products, impacting profitability.
Global TiO2 Market Weakness: Sustained macro weakness in the global TiO2 market, compounded by seasonal trends and destocking, led to underperformance in the TT segment.
Excess Inventory in TiO2 Market: Excess inventory from Western producers and Chinese exports created oversupply, pressuring pricing and market conditions.
Production Volume Reductions: Lower production volumes in the TT segment to align with muted demand resulted in a $25 million cost impact to adjusted EBITDA.
Seasonality and Destocking: Seasonal trends and near-term destocking in the TT segment are expected to continue, impacting sales and earnings.
Freon Business Decline: Declines in the Freon business are anticipated to offset growth in Opteon sales, affecting the TSS segment's overall performance.
Market Sensitivity in APM: Global industrial end markets' weakness, sensitive to macroeconomic conditions, is expected to impact APM's sales and earnings.
Cost Impacts from Lower Circuit Operations: Lower circuit operations in the TT segment may mask the benefits of cost reductions, impacting financial performance.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
TSS Segment Outlook: For the fourth quarter, net sales are expected to decrease sequentially in the high teens to low 20s percentage range due to traditional seasonality, with continued double-digit Opteon growth. Adjusted EBITDA is projected to range between $125 million and $140 million. Continued investments in next-generation refrigerants and liquid cooling solutions are anticipated, with product development costs estimated at $8 million for the quarter and $40 million for the full year. Double-digit year-over-year Opteon growth is expected to continue into early 2026, supported by OEM transitions to R-454B in the U.S. Margins are expected to expand over time due to cost-out efforts and expanded capacity.
APM Segment Outlook: Net sales are expected to decrease in the low single-digit percentage range sequentially due to market weakness in global industrial end markets. Adjusted EBITDA is projected to range between $30 million and $40 million in the fourth quarter. Operational excellence and cost reduction efforts are expected to drive normalized earnings levels, which are anticipated to continue in future quarters.
TT Segment Outlook: Net sales are expected to decrease sequentially in the high single digits to low teens percentage range due to seasonality, regional sales mix, and near-term destocking, which is expected to persist until the end of 2025. Adjusted EBITDA is projected to range between $15 million and $20 million. Production volumes have been lowered to align with muted market demand, resulting in a $25 million cost impact in the fourth quarter. Restocking efforts are anticipated in the first quarter of 2026, with improved earnings expected as operational performance improves. Muted market conditions are expected to persist in the near term, with a focus on promoting cash generation and aligning production with demand.
Consolidated Guidance: Fourth quarter net sales are expected to decrease 10% to 15% sequentially, with adjusted EBITDA ranging between $130 million and $160 million. Corporate expenses are projected to range between $40 million and $45 million. Capital expenditures for the fourth quarter are expected to be approximately $50 million, with free cash flow conversion between 50% and 70%. Full-year 2025 sales are expected to range between $5.7 billion and $5.8 billion, with adjusted EBITDA between $745 million and $770 million and capital expenditures of $220 million. For 2026, overall sales and earnings growth are anticipated, supported by cost-out efforts and improved cash flow performance.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why does Chemours not expect a volume speed bump in the TSS business despite challenges in the residential HVAC OEM market?
A:Chemours has a broad portfolio outside of HVAC OEMs, focusing on maximizing value across applications, products, and regions. They expect double-digit growth into the fourth quarter and 2026, with refrigerant sales up 32% year-over-year, Opteon sales up 80%, and segment sales up 20% with margin expansion from 30% to 35%.
Q:Does Chemours have the bandwidth to manage its various opportunities, including data centers, critical minerals, and core businesses?
A:Management feels confident in their Pathway to Thrive strategy, which focuses on operational excellence, cost reduction, portfolio management, and strengthening the long term. They aim to optimize shareholder value and maintain a strong balance sheet.
Q:What operational improvements have been made in the TT business to address disruptions?
A:Chemours has implemented contingency plans, brought in strong operational leadership, established a manufacturing COE, and standardized operating systems. They anticipate no further one-off operational issues and are focused on cost optimization.
Q:What gives Chemours confidence in implementing the TiO2 price increase in December despite weak global demand?
A:Chemours has seen price stability in fair trade markets and expects destocking to end, with customers restocking in Q1. They are confident due to stability in EMEA and North America and resolution of issues like Indian tariffs and inventory liquidation.
Q:How fast does Chemours expect the HFO replacement market to develop, and will it be financially material in the next 18-24 months?
A:Chemours expects double-digit Opteon growth into 2026, driven by the HFO transition in both OEM and aftermarket segments.
Q:What were the main factors behind the shortfall in TT segment EBITDA and overall company performance in 2025?
A:The shortfall was due to weaker TiO2 demand, tariff and duty uncertainties, and operational disruptions. However, Chemours achieved $125 million in cost reductions and strong performance in the TSS business.
Q:What are the drivers for TSS growth in 2026?
A:Drivers include continued OEM transition (75% complete), aftermarket growth, cost optimization from Corpus Christi expansion, and reduced costs related to next-generation refrigerants and liquid cooling ventures.
Q:What steps is Chemours taking to avoid operational disruptions in the future?
A:Chemours is focusing on operational excellence, investing in manufacturing COE, leadership, and standardized processes to ensure reliability and growth.
Q:What was the impact of the liquid cooling investment on TSS EBITDA, and what caused the variance?
A:The liquid cooling investment caused a $22 million impact on TSS EBITDA due to a noncash charge related to product development. This was higher than the expected $5 million.
Q:How sustainable are the recent TSS performance gains, and what role does the Corpus Christi expansion play?
A:Chemours believes the gains are sustainable due to strong commercial execution and aftermarket growth. The Corpus Christi expansion will contribute to cost optimization and earnings growth in 2026.
Q:What is the opportunity for Chemours in fair markets like Europe, Brazil, and India due to changes like ADD and Venator liquidation?
A:Chemours sees an opportunity to grow share in fair markets, with an estimated 800 kilotons of volume available across these regions.
Q:How important is Rio Tinto's African ore to Chemours' operations, and what would happen if it fell into competitors' hands?
A:Chemours has a diverse portfolio of ores and does not see any material impact from changes in Rio Tinto's African operations.
Q:What is the expected impact of destocking on Chemours' TT business in 2025?
A:Destocking impacted both producers and the customer value chain, primarily in Q3 and Q4. However, share gains and commercial diligence helped offset some of the volume impacts.
Q:How important are architectural coatings to Chemours' TT business?
A:Architectural coatings account for approximately 70% of Chemours' TT business.
Q:What is Chemours' approach to addressing forever chemicals in refrigerants and fluoropolymers?
A:Chemours is innovating next-generation refrigerants and continues to reinvent the category to address environmental concerns.
Q:Is there price erosion in the U.S. TiO2 market?
A:Chemours has seen price stability in the U.S. TiO2 market in 2025, despite a year-over-year decline. They are moving forward with a price increase.
Q:When does Chemours expect a ruling on Indian tariffs?
A:Chemours expects a ruling on Indian tariffs by the end of the year.
Q:What volume growth is needed for Chemours to fully realize the benefits of Pathway to Thrive in the TiO2 segment?
A:A modest increase in demand is expected to get Chemours on track to fully realize the benefits of Pathway to Thrive.
Q:What is Chemours' strategy for upcoming debt maturities?
A:Chemours plans to be opportunistic in refinancing, considering different structures to avoid disruptions. They have significant secured debt capacity.
Q:What is the impact of Venator's inventory liquidation on the TiO2 market?
A:Venator's inventory liquidation materially impacted Q3 pricing and volumes but is expected to be resolved by the end of Q4.
Q:Review of Unclear Management Responses
A:Management avoided providing specific numbers or clarity on the following:
1. Quantifying the net headwind from destocking in the TT business.
2. Details on the real estate strategy and potential monetization.
3. Specific impacts of Venator's inventory liquidation on pricing and volumes.
4. Exact volume growth needed to fully realize Pathway to Thrive benefits in the TiO2 segment.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AIM Act
APM agreement
Refrigerants
Washington Works
achievement
aftermarket
approach
benefit cost
cash generation
circuit
condition
connection
cost reduction
equipment transition
expectation weakness
focus excellence
issue
market demand
mineral
percentage seasonality
perspective
product development
production cost
progress cost
quarter
reliability
remark
response
sale digit
system
teen percentage
term cash
term destocking
timing
trade action
yesterday evening
CC Transcript
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
Unknown5-6
The earnings call summary highlights several negative financial indicators, including a 10% decline in revenue, a 15% drop in net income, and a 12% decrease in adjusted EBITDA. Additionally, the free cash flow and gross margin have declined, and forward-looking statements indicate potential risks. The absence of positive strategic initiatives or operational updates further contributes to a negative sentiment. Given the market cap of $3.4 billion, the stock price is likely to experience a negative movement of -2% to -8% over the next two weeks.
The Chemours Company (CC) Q4 2025 Earnings Call Transcript
Unknown2-20
The earnings call summary reflects a negative sentiment due to several factors: expected sequential declines in net sales across segments, muted market conditions, and significant cost impacts. Despite some positive elements like Opteon growth and cost-out efforts, the overall guidance indicates a challenging environment. The Q&A session highlighted concerns about inventory levels, market weakness, and unclear management responses regarding capacity rationalizations and market share gains. Given the company's mid-cap size, these challenges are likely to result in a negative stock price movement in the short term.
The Chemours Company (CC) Q3 2025 Earnings Call Transcript
Unknown11-7
The earnings call summary indicates declining sales and EBITDA across multiple segments, operational disruptions, and financial shortfalls. Although there are some positive aspects like cost reductions and strategic growth plans, the overall sentiment is negative due to weak guidance, operational issues, and market uncertainties. The Q&A section further highlights concerns over demand, tariffs, and inventory issues. Given the company's market cap and the negative aspects outweighing positives, a negative stock price movement is anticipated.
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
Positive8-6
The earnings call summary shows strong financial performance, with significant growth in key segments like TSS and Advanced Materials. The strategic agreement with Navin Fluorine and cost reduction initiatives further enhance the outlook. The Q&A section reveals management's confidence in overcoming operational challenges and achieving long-term growth, despite some uncertainties. The market cap suggests a moderate reaction, leading to a positive forecast of 2% to 8% stock price increase over the next two weeks.
CC Slides
CC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
